Dr. Sofija Jovanović Stojanov

RESEARCH FIELD
Multidrug resistance in cancer; Mechanisms of action of new antitumor agents with the potential to overcome multidrug resistance; Development of new cell models and assays for preclinical testing of antitumor agents

EDUCATION
2011-2018 PhD degree at the Faculty of Biology, University of Belgrade, Serbia
2004-2011 Undergraduate studies of Molecular Biology and Physiology; University of Belgrade, Faculty of Biology, Belgrade, Serbia

EMPLOYMENT HISTORY
2019-present Department of Neurobiology, Institute for Biological Research “Siniša Stanković” - National Institute of Republic of Serbia (Belgrade, Serbia)
2012-2019 Department of Molecular Biology, Institute for Biological Research “Siniša Stanković” - National Institute of Republic of Serbia (Belgrade, Serbia)

SCIENTIFIC PROJECTS AND COLLABORATIONS
• Team member on Project: The Program PRISMA - Biomimetic tumor engineering to enhance drug discovery (BioengineeredTumor), Science Fund of the Republic of Serbia (2024-2027)
• Team member on Project: The Program IDEAS - Functional diagnostics in non-small cell lung carcinoma – a new concept for the improvement of personalized therapy in Serbian patients (TargetedResponse), Science Fund of the Republic of Serbia (2022–2024)
• Team member on Project: 173020 “Signaling Molecules in Diabetes: Search for Potential Targets in Intrinsic Pathways for Prediction and Intervention in Diabetes” Ministry of Education, Science and Technological Development (MPNTR), Republic of Serbia (2012 – 2019)
• Member of COST Action CA17104: New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors (STRATAGEM) (2018 – 2022)

PROFESSIONAL MEMBERSHIP
1. Member of the Federation of European Neuroscience Societies from 2023
2. Member of the Serbian Biological Society from 2022
2. Member of the Serbian Association for Cancer Research from 2020
3. Member of the European Association for Cancer Research from 2020